Universal CAR-T Cells Targeting Multiple Myeloma
Condition: Multiple Myeloma in Remission Intervention: Biological: MM-specific universal CAR T cells Sponsors: Shenzhen Geno-Immune Medical Institute; The Second Affiliated Hospital of Hainan Medical University; Beijing Jingdu Children's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)
Condition: Myeloma Intervention: Sponsor: The Christie NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Universal CAR-T Cells Targeting Multiple Myeloma
Condition: Multiple Myeloma in Remission Intervention: Biological: MM-specific universal CAR T cells Sponsors: Shenzhen Geno-Immune Medical Institute; The Second Affiliated Hospital of Hainan Medical University; Beijing Jingdu Children's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)
Condition: Myeloma Intervention: Sponsor: The Christie NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Universal CAR-T Cells Targeting Multiple Myeloma
Condition: Multiple Myeloma in Remission Intervention: Biological: MM-specific universal CAR T cells Sponsors: Shenzhen Geno-Immune Medical Institute; The Second Affiliated Hospital of Hainan Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
